ATE525654T1 - Verfahren zum screenen von verbindungen, welche die gpi biosynthese von malariaparasiten hemmen - Google Patents
Verfahren zum screenen von verbindungen, welche die gpi biosynthese von malariaparasiten hemmenInfo
- Publication number
- ATE525654T1 ATE525654T1 AT03774152T AT03774152T ATE525654T1 AT E525654 T1 ATE525654 T1 AT E525654T1 AT 03774152 T AT03774152 T AT 03774152T AT 03774152 T AT03774152 T AT 03774152T AT E525654 T1 ATE525654 T1 AT E525654T1
- Authority
- AT
- Austria
- Prior art keywords
- present
- gwt1
- protein
- gpi biosynthesis
- malaria parasite
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 238000012216 screening Methods 0.000 title abstract 3
- 201000004792 malaria Diseases 0.000 title abstract 2
- 244000045947 parasite Species 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 101001074628 Homo sapiens Phosphatidylinositol-glycan biosynthesis class W protein Proteins 0.000 abstract 3
- 102100036253 Phosphatidylinositol-glycan biosynthesis class W protein Human genes 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 239000003430 antimalarial agent Substances 0.000 abstract 2
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 241000223960 Plasmodium falciparum Species 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 230000002950 deficient Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
- G01N2333/445—Plasmodium
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42858902P | 2002-11-22 | 2002-11-22 | |
| PCT/JP2003/014920 WO2004048567A2 (en) | 2002-11-22 | 2003-11-21 | Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE525654T1 true ATE525654T1 (de) | 2011-10-15 |
Family
ID=32393427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03774152T ATE525654T1 (de) | 2002-11-22 | 2003-11-21 | Verfahren zum screenen von verbindungen, welche die gpi biosynthese von malariaparasiten hemmen |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7928215B2 (de) |
| EP (1) | EP1565749B9 (de) |
| JP (3) | JP4315907B2 (de) |
| KR (4) | KR100825547B1 (de) |
| CN (3) | CN100504392C (de) |
| AT (1) | ATE525654T1 (de) |
| AU (1) | AU2003282393B2 (de) |
| CA (3) | CA2721200A1 (de) |
| WO (1) | WO2004048567A2 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1249227C (zh) * | 2000-07-07 | 2006-04-05 | 卫材株式会社 | 真菌细胞壁合成基因 |
| JP4061309B2 (ja) * | 2002-11-22 | 2008-03-19 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Gwt1遺伝子産物の酵素活性を阻害する化合物をスクリーニングする方法 |
| US7932272B2 (en) | 2003-09-30 | 2011-04-26 | Eisai R&D Management Co., Ltd. | Antifungal agent containing heterocyclic compound |
| EP1782811A4 (de) | 2004-08-09 | 2010-09-01 | Eisai R&D Man Co Ltd | Neues anti-malaria-mittel mit heterozyklischer verbindung |
| WO2006106711A1 (ja) | 2005-03-30 | 2006-10-12 | Eisai R & D Management Co., Ltd. | ピリジン誘導体を含有する抗真菌剤 |
| TWI385169B (zh) | 2005-10-31 | 2013-02-11 | Eisai R&D Man Co Ltd | 經雜環取代之吡啶衍生物及含有彼之抗真菌劑 |
| WO2008035726A1 (en) | 2006-09-21 | 2008-03-27 | Eisai R & D Management Co., Ltd. | Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same |
| TW200841879A (en) | 2007-04-27 | 2008-11-01 | Eisai R&D Man Co Ltd | Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same |
| JP5354542B2 (ja) * | 2007-09-14 | 2013-11-27 | 国立大学法人 長崎大学 | 熱帯熱マラリアワクチン候補分子 |
| US8513287B2 (en) | 2007-12-27 | 2013-08-20 | Eisai R&D Management Co., Ltd. | Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same |
| JP5646457B2 (ja) | 2008-04-29 | 2014-12-24 | アッヴィ・インコーポレイテッド | 二重可変ドメイン免疫グロブリン及びその使用 |
| JP2011523853A (ja) | 2008-06-03 | 2011-08-25 | アボット・ラボラトリーズ | 二重可変ドメイン免疫グロブリン及びその使用 |
| US8188119B2 (en) | 2008-10-24 | 2012-05-29 | Eisai R&D Management Co., Ltd | Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same |
| UY33492A (es) | 2010-07-09 | 2012-01-31 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
| EP3252072A3 (de) | 2010-08-03 | 2018-03-14 | AbbVie Inc. | Immunglobuline mit zweifacher variabler domäne und verwendungen davon |
| WO2013192517A2 (en) * | 2012-06-21 | 2013-12-27 | Whitehead Institute For Biomedical Research | Compounds for treating infectious diseases |
| KR102063576B1 (ko) * | 2012-07-24 | 2020-01-10 | 한국전자통신연구원 | 가상화 기반 은닉형 소프트웨어 실행 환경 제공 방법 및 장치 |
| KR101954733B1 (ko) * | 2012-10-26 | 2019-03-06 | 삼성전자주식회사 | 보안 콘텐츠를 처리하는 시스템 온 칩 및 그것을 포함하는 모바일 장치 |
| CN109825514A (zh) * | 2019-01-24 | 2019-05-31 | 华中农业大学 | 田鼠巴贝斯虫gpi10基因及其编码的蛋白和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2015722A1 (en) * | 1989-05-03 | 1990-11-03 | Mitchell S. Gross | Malaria vaccine |
| DE19640817A1 (de) | 1996-10-02 | 1998-05-14 | Hermann Prof Dr Bujard | Rekombinantes Herstellungsverfahren für ein vollständiges Malaria-Antigen gp190/MSP 1 |
| WO1999021986A1 (en) * | 1997-10-29 | 1999-05-06 | Shanghai Second Medical University | Cbfbga09: a human sl15 homolog |
| AU2392300A (en) | 1998-12-31 | 2000-07-31 | Millennium Pharmaceuticals, Inc. | Use of essential (saccharomyces) genes and polypeptides |
| WO2001013923A1 (en) | 1999-08-20 | 2001-03-01 | Georgetown University | Malaria gpi anchors as vaccines anti-parasitic drugs and for use in diagnostics |
| CN1249227C (zh) * | 2000-07-07 | 2006-04-05 | 卫材株式会社 | 真菌细胞壁合成基因 |
| US20040038239A1 (en) * | 2000-07-07 | 2004-02-26 | Kappei Tsukahara | Fungal cell wall synthesis gene |
| AU2002225533A1 (en) | 2000-12-22 | 2002-07-08 | Stichting Biomedical Primate Research Centre | Efficient expression of plasmodium apical membrane antigen 1 in yeast cells |
| DE10254397B4 (de) | 2002-11-21 | 2010-09-23 | Poloplast Gmbh & Co. Kg | Universalschlauchkupplung |
| JP4061309B2 (ja) * | 2002-11-22 | 2008-03-19 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Gwt1遺伝子産物の酵素活性を阻害する化合物をスクリーニングする方法 |
-
2003
- 2003-11-21 AT AT03774152T patent/ATE525654T1/de not_active IP Right Cessation
- 2003-11-21 EP EP03774152A patent/EP1565749B9/de not_active Expired - Lifetime
- 2003-11-21 CN CNB2003801091050A patent/CN100504392C/zh not_active Expired - Fee Related
- 2003-11-21 JP JP2004555010A patent/JP4315907B2/ja not_active Expired - Fee Related
- 2003-11-21 CA CA2721200A patent/CA2721200A1/en not_active Abandoned
- 2003-11-21 CN CN2007101042868A patent/CN101092627B/zh not_active Expired - Fee Related
- 2003-11-21 CA CA2505067A patent/CA2505067C/en not_active Expired - Fee Related
- 2003-11-21 CN CN2007101042872A patent/CN101092628B/zh not_active Expired - Fee Related
- 2003-11-21 US US10/535,928 patent/US7928215B2/en not_active Expired - Fee Related
- 2003-11-21 CA CA2704070A patent/CA2704070A1/en not_active Abandoned
- 2003-11-21 KR KR1020057009212A patent/KR100825547B1/ko not_active Expired - Fee Related
- 2003-11-21 AU AU2003282393A patent/AU2003282393B2/en not_active Ceased
- 2003-11-21 KR KR1020077012681A patent/KR20070065452A/ko not_active Ceased
- 2003-11-21 WO PCT/JP2003/014920 patent/WO2004048567A2/en not_active Ceased
- 2003-11-21 KR KR1020107004569A patent/KR20100039428A/ko not_active Ceased
- 2003-11-21 KR KR1020067027915A patent/KR100933759B1/ko not_active Expired - Fee Related
-
2008
- 2008-09-22 JP JP2008242395A patent/JP2009077715A/ja active Pending
-
2009
- 2009-03-24 JP JP2009071722A patent/JP4376297B2/ja not_active Expired - Fee Related
-
2011
- 2011-03-04 US US13/040,970 patent/US8252294B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070065452A (ko) | 2007-06-22 |
| JP2006506996A (ja) | 2006-03-02 |
| CA2704070A1 (en) | 2004-06-10 |
| JP2009183290A (ja) | 2009-08-20 |
| EP1565749A2 (de) | 2005-08-24 |
| JP2009077715A (ja) | 2009-04-16 |
| AU2003282393B2 (en) | 2007-07-05 |
| KR20100039428A (ko) | 2010-04-15 |
| WO2004048567A2 (en) | 2004-06-10 |
| US8252294B2 (en) | 2012-08-28 |
| KR100825547B1 (ko) | 2008-04-25 |
| CN101092627A (zh) | 2007-12-26 |
| CN101092628A (zh) | 2007-12-26 |
| KR100933759B1 (ko) | 2009-12-23 |
| WO2004048567A3 (en) | 2004-10-14 |
| EP1565749B1 (de) | 2011-09-21 |
| CN101092628B (zh) | 2010-11-03 |
| CN101092627B (zh) | 2011-08-17 |
| JP4315907B2 (ja) | 2009-08-19 |
| JP4376297B2 (ja) | 2009-12-02 |
| CA2505067A1 (en) | 2004-06-10 |
| KR20050085105A (ko) | 2005-08-29 |
| CA2505067C (en) | 2011-08-02 |
| CN1742203A (zh) | 2006-03-01 |
| AU2003282393A1 (en) | 2004-06-18 |
| EP1565749B9 (de) | 2012-04-25 |
| CA2721200A1 (en) | 2004-06-10 |
| US7928215B2 (en) | 2011-04-19 |
| CN100504392C (zh) | 2009-06-24 |
| US20110201816A1 (en) | 2011-08-18 |
| US20060172404A1 (en) | 2006-08-03 |
| KR20070010088A (ko) | 2007-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE525654T1 (de) | Verfahren zum screenen von verbindungen, welche die gpi biosynthese von malariaparasiten hemmen | |
| Cravo et al. | How genomics is contributing to the fight against artemisinin-resistant malaria parasites | |
| ATE408422T1 (de) | Methode zur hemmung immunstimulatorischer mit dna assoziierter antworten | |
| IL164757A0 (en) | Method for analyzing an alpha-galactosidase a preparation | |
| WO2003016475A3 (en) | Nucleic acid and amino acid sequences involved in pain | |
| AU2003275112A1 (en) | System, method and computer program product for subsurface contamination detection and analysis | |
| WO2003074734A3 (en) | Methods for detecting genome-wide sequence variations associated with a phenotype | |
| Pollitt et al. | Rapid response to selection, competitive release and increased transmission potential of artesunate-selected Plasmodium chabaudi malaria parasites | |
| TW200714716A (en) | Method | |
| DK1842920T4 (da) | Celler der co-udtrykker K-vitaminreduktase og K-vitaminafhængigt protein, samt anvendelse deraf til at forbedre produktiviteten af det K-vitaminafhængige protein | |
| AU2003287491A8 (en) | Preformulation analysis and optimization | |
| TWI349861B (en) | Structured document processor, structured document processing method and computer program product | |
| WO2004081721A3 (en) | Method and apparatus for pattern identification in diploid dna sequence data | |
| WO2000034652A8 (en) | Methods of identifying point mutations in a genome | |
| Igwe et al. | Evolutionary biology of antimalarial drug resistance: Understanding of the evolutionary dynamics | |
| WO2004017042A3 (en) | Methods and reagents for surface functionalization | |
| WO2002081746A3 (en) | A method for identifying constitutively active mutants of mitogen activated protein kinases (mapk) and uses thereof | |
| AU2003285775A1 (en) | Method for identifying, analyzing and/or cloning nucleic acid isoforms | |
| WO2004041076A3 (en) | Methods of detecting colorectal cancer | |
| WO2003033738A3 (en) | Polymorphic marker that can be used to assess the efficacy of interferon therapy | |
| WO2003048386A3 (fr) | Procede de detection et d'analyse quantitative de molecules d'acides nucleiques comprenant une etape d'extraction par une base forte et applications. | |
| Thongdee et al. | Genetic polymorphisms in Plasmodium vivax dihydrofolate reductase and dihydropteroate synthase in isolates from the Philippines, Bangladesh, and Nepal | |
| ATE464553T1 (de) | Verfahren zur herzerkrankungsbewertung in einer einzelperson | |
| GB0305656D0 (en) | Screening assay | |
| WO2004037848A3 (en) | Process for determining target function and identifying drug leads |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |